Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy

Oral drug delivery systems had natural potential for colorectal cancer drug therapy. While the drug delivery efficiency is severely hindered by the complex intestinal barriers, especially mucus and epithelium barriers, resulting in unsatisfactory therapeutic effects and limited clinical translation. In this work, a bioactive self-thermophoretic and gas dual-driven nanomotor is developed for colorectal cancer therapy through efficient intestinal mucus and epithelial barrier penetration. The nanomotor shows intestinal mucus barrier penetration and the paracellular pathway reversibly opening properties of intestinal epithelium barrier, increasing the delivery efficiency of cisplatin by 3.5 folds. Owing to the targeted delivery of cisplatin and the reduced side effects on normal intestinal tissues, the therapeutic efficiency of the nanomotor for colorectal cancer in vivo is as high as 98.6%. With autonomous and reversible intestinal barriers penetration property, the nanoplatform may innovate the current oral drug delivery.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-02-16
DOI
https://doi.org/10.1038/s41467-025-57045-9
Citations
41
Primary Topic
Micro and Nano Robotics
Type
article
Field-Weighted Citation Impact
51.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy

Mingzhu Yang, Jinjin Shi, Fengqin Zhao, Junjie Liu et al.
41 citations
Nature Communications
Micro and Nano Robotics
51.58
article

Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy

Mingzhu Yang, Jinjin Shi, Fengqin Zhao, Junjie Liu, Shuhao Zhang, Zhi‐Hao Wang, Airong Li, Xuejiao Zeng, Yanbo Yang, Wanting Huang, Hua Liu, Zhenzhong Zhang
article en
41 citations

Abstract

Oral drug delivery systems had natural potential for colorectal cancer drug therapy. While the drug delivery efficiency is severely hindered by the complex intestinal barriers, especially mucus and epithelium barriers, resulting in unsatisfactory therapeutic effects and limited clinical translation. In this work, a bioactive self-thermophoretic and gas dual-driven nanomotor is developed for colorectal cancer therapy through efficient intestinal mucus and epithelial barrier penetration. The nanomotor shows intestinal mucus barrier penetration and the paracellular pathway reversibly opening properties of intestinal epithelium barrier, increasing the delivery efficiency of cisplatin by 3.5 folds. Owing to the targeted delivery of cisplatin and the reduced side effects on normal intestinal tissues, the therapeutic efficiency of the nanomotor for colorectal cancer in vivo is as high as 98.6%. With autonomous and reversible intestinal barriers penetration property, the nanoplatform may innovate the current oral drug delivery.

Nature CommunicationsVol. 16(1)
Ministry of Education (NZ), Ministry of Education of the People's Republic of China (CN), Chinese Center For Disease Control and Prevention (CN), Zhengzhou University of Light Industry (CN), North Central Cancer Treatment Group (US), Zhengzhou University (CN), Zhengzhou Institute of Machinery (CN), Zhengzhou Business University (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Zhengzhou University
Good health and well-being
Openalex Percentile: Top 0%
Micro and Nano Robotics
51.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.